Trials / Conditions / Relapsed Osteosarcoma
Relapsed Osteosarcoma
6 registered clinical trials studyying Relapsed Osteosarcoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma NCT07211737 | Baylor College of Medicine | Phase 1 |
| Recruiting | Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma NCT07144254 | Emory University | Phase 1 |
| Recruiting | Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or R NCT05400603 | Emory University | Phase 1 |
| Completed | Cabozantinib With Topotecan-Cyclophosphamide NCT04661852 | Dana-Farber Cancer Institute | Phase 1 |
| Active Not Recruiting | C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL NCT03635632 | Baylor College of Medicine | Phase 1 |
| Completed | Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarc NCT01804374 | Italian Sarcoma Group | Phase 2 |